Redhill Biophrma ADR (RDHL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Sales | 1,523 | 483 | 0 | 100 | 0 |
| Cost of Goods | 935 | 272 | N/A | N/A | N/A |
| Gross Profit | 588 | 211 | N/A | 100 | N/A |
| Operating Expenses | 15,488 | 14,022 | 10,102 | 9,092 | 8,454 |
| Operating Income | -13,965 | -13,539 | -10,102 | -8,992 | -8,454 |
| Interest Expense | 1,697 | 7 | 50 | -249 | 599 |
| Other Income | 150 | 2,523 | 1,556 | 393 | 109 |
| Pre-tax Income | -15,512 | -11,023 | -8,596 | -8,350 | -8,944 |
| Net Income Continuous | -15,512 | -11,023 | -8,596 | -8,350 | -8,944 |
| Net Income | $-15,512 | $-11,023 | $-8,596 | $-8,350 | $-8,944 |
| EPS Basic Total Ops | -900.00 | -600.00 | -500.00 | -654.40 | -701.60 |
| EPS Basic Continuous Ops | -903.55 | -642.37 | -505.35 | -634.69 | -701.63 |
| EPS Diluted Total Ops | -900.00 | -600.00 | -500.00 | -554.40 | -701.60 |
| EPS Diluted Continuous Ops | -903.55 | -642.37 | -505.35 | -635.38 | -701.63 |
| EBITDA(a) | $-13,939 | $-13,521 | $-10,088 | $-8,980 | $-8,443 |